An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims


A so-called monoclonal antibody lowered blood levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts. (Ny Times Science) More More

Similar stories

Racing ahead of Merck and Innovent, Junshi declares PhIII success on cancer that won them 'breakthrough' status - Endpoints News

Racing ahead of Merck and Innovent, Junshi declares PhIII success on cancer that won them 'breakthrough' status  Endpoints News

Posted on 28 September 2020 | 9:53 pm | Google News

Regeneron offers a positive look at the first cut of its Covid-19 antibody cocktail — but just how well does it protect a vulnerable group? - Endpoints News

Regeneron offers a positive look at the first cut of its Covid-19 antibody cocktail — but just how well does it protect a vulnerable group?  Endpoints News

Posted on 28 September 2020 | 9:21 pm | Google News

Coronavirus tracker: SII steps up to produce 100M more COVAX doses; Orgenesis snags COVID-19 cell therapy in Koligo buyout - FiercePharma

Coronavirus tracker: SII steps up to produce 100M more COVAX doses; Orgenesis snags COVID-19 cell therapy in Koligo buyout  FiercePharma

Posted on 28 September 2020 | 2:30 pm | Google News

Drug prices: Why prescription medicines are unaffordable for many people - Journalist's Resource

Drug prices: Why prescription medicines are unaffordable for many people  Journalist's Resource

Posted on 28 September 2020 | 5:00 am | Google News

With a $4M federal grant, Lumen jumps into the Covid-19 treatment race - Endpoints News

With a $4M federal grant, Lumen jumps into the Covid-19 treatment race  Endpoints News

Posted on 24 September 2020 | 6:06 am | Google News

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers - Nasdaq

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers  Nasdaq

Posted on 23 September 2020 | 8:05 am | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info